The FDA is set to decide by June 10 ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...

KHINDIVI is the only FDA-approved oral solution formulation of ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

Geron is an undervalued company with a potential for significant revenue growth, especially via its first-in-class drug ...

Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

Shares of Guardant Health Inc (NASDAQ:GH) climbed 3.7% as the company announced its Shield multi-cancer detection (MCD) test received Breakthrough Device designation from the U.S. Food and Drug ...

Amylyx Pharmaceuticals (NASDAQ:AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...

"Sickle cell disease is a devasting disorder that affects approximately 100,000 people in the U.S., leading to anemia, severe ...

Shares of Ascendis Pharma A/S (NASDAQ:ASND) climbed 5.8% today after the company announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application ...

U.S. steel stocks, more. Wall Street sees more weakness ahead for U.S. dollar. Indivior to delist from London Stock Exchange, ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

ImmunityBio (NASDAQ:IBRX) said on Monday that the U.S. FDA has approved expanded access for its Cancer BioShield platform, ...